Outcome Of Board Meeting Held On 5th November, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended September 30, 2026.

BRAWN BIOTECH LTD. November 5,2026 BSE Limited, Department of Corporate Services, Phiroze Jegjecbhoy Towers, Dalal Street, Fort, Mumbai - 400001 Serip Code: 530207 Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Outcome of Board Meeting held on November 5, 2026 Dear Sir/Ma’am, W tS Roi E edt B vah I iy , er L we 5if ®se Rt r N eie o pnn og vc ree R tm e t g bo bu e ylt r ah , tte h i 2 ec o 0 a n C2p s ot , 6i m t ho ph an i ase s n d ci y s os ’ ntu sob s j ii Se d tnc e aft r to e ua r d tn m od a ry n yp o d u u A r a us t p dhu p iaa trtn o ot t rv ht ee fo d oB t rtoh hae te hr p eUdr n o Qo -v uf Ai a Ds u rii d tro i een rtcs et eo do nrf T ds FR eioe dnfg a u t 3nl ch 0a ie .at 0C li 9 o o R .n e 2m s 0p3 u 20 a l 6 n t ,a s yn a ad i l CnR o oe i nt pg gsu y m wl iea otet fhti wio L hnn ig im3 cih3 hte l eo id df s enclosed herewith. We wish to further inform you that the meeting of the board of directors commenced at 2:00 PM. and concluded at2.30 PM. Kindly take the same on your record and acknowledge receipt of the same. Thanking you, Yours faithfully, For and on behalf of Brawn Biotech Limited Company Secretary & Compliance Officer Membership No. A50385 CIN NO.: L74899DL1985PLC022468 <. for betten e Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331 . Email: solution@brawnbiotech.com '\ Works Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram - 122001, Haryana, INDIA BRAWN BIOTECH LTD. Email: distribution@brawnlabs.in | Website : www.brawngroup.in BRAWN BIOTECH LTD. "BRAWN BIOTECH LIMITED CINA74899DL1985PLC022468 REGD. OFFICE: C-64, Lajpat Nagar-1, New Delhi 110024 Extract oS tandalone Un-Audited Finaneial Resultsfor the quarter and half year ended 30th September 2026 (Rs. In Lacs} e, Particulars Quarter Ended Halfyearly ended Year Ended No. 305cp26_|_ 30Jun26 | 30Sep25 | 30Sep26 | 30Sep2s | 3iMarze Un-audited | _Un-audited | Un-audited | Unaudited | Un-audited Audited 1 |Revenue from operations Revenue from operations S6245 0788 18910 117033 1068.87 1697.77 Other Income 1411 1385 512 27.96 1821 4540 [Total Revenue 57656 62174 29822 119829 1,087.08 1783.18 2 [Bxpenses a [Cost of material consumed - - - . - 5 b [Purchase of stock-in-trade 14984 22350 53648 673.34 97769 Ta114s Change In nventories of inished §o0d5, workn progresansd ¢ |stockn trade 2024 29534 12052 32358 1560 1049 4 [Employee Benefltexpenses 2220 3055 1455 5275 3507 6836 e [Depreciation and amortisation expenses 298 299 310 557 617 1220 T_[Finance Cost 014 00z 018 0.6 021 045 & [Other expenses 70.13 5390 57.27 12403 10275 21013 [Total Expenses 573.53 60630 491.08 117983 105634 1743.07 Profit from Operation before Other Tncome, exceptional 3 |and extra-ordiniatermys (1-2) 303 1504 734 18.46 3074 o1 4 [Other Income s = = . . - Profitirom ordimary aciivities before exceptional ltems 5G4 303 1544 714 18.46 3078 o1 6 [Exceptional ltems. B - - - 5 7 |Profit from ordinary activities before tax (5-6) 303 154 734 1846 307 o011 8 [Tax Expenses - - B 5395 Profit (Loss) for the period from continuing operations (7 92 le) 303 1544 714 1845 3074 9406 10 |Profit/(loss) from discontinuing operations - - = 3 11 [Tax expense of discontinuing operations 5 - 5 - Profit/(10s5) from Discontinuing operations (after tax) N - " 12 |poa1) = 13 | Profit (Loss) for the period (3+12) 303 544 718 1846 3074 5806 14 [Other Comprehensive Income 070 009 035 079 355 365 Total Comprehensive Income 37 1553 7.49 1926 34,30 5771 15 [Detailsof equiy share capial 30003 30003 30003 30003 300,03 30003 Paid-up equity share capital [Face value o cquity share capital 16 [ Reserve excluding Revaluation Reserve 17 |Earnings per share 1 [Basic carnpiern sghasre [XP) [X) 025 064 11 326 i [Diluted carnings per share. o1 052 025 064 114 326 [NoTES 1 Resuitsfor the quarter and hlfyear ended on 30th September, 2026 were reviebwy ethde Audit commitae and then approved by the 8oard of Directato thresir mesting heid on St November, 2026, 2 The Statutory Auditors cariote tdhe limited review o quarter and halfyear ended 30th September, 2026. The managehasm exeernclted necassary due diigence to ensure that the inancial rasuls provided a true and aiv ieo wts affars. 3 Tne above resuts have been prepared n accordance with the recogntion and measurement princples of Ind AS 34 Interm Financia Reporting”, rescrbed under Secion 133 of the| Companies Act, 2013 read with the Companles (ndian Accounting Standards) Rues, 2015, s amended from time to time, and other accounting princples generally accepted in Indi, nd| i complsnce with Regula3t3 iofo thne SEBI (Listing Oblgations and Dislosure Requiremets) Regulatons, 20as1 am5end,ed. 4 The Company isengaged primarly I the busofi Phanrmaeceutsicasls, Accordingy,there Isno separate reportabls segments s per Ind-AS 108 deawilth iOpenratging Segments. 5 The above Standalone Un- audited Financial Resultsforthe quarter and halfyear ended on 30-09-2026 are avalable on company's website www.brawnbiotech.com and BSE website vewwbseindia.com. X & broviousyear / perod figures have been regro/ reuarpranegedd, wherever necessary to make them comparwaibthl tehe current period figres. For and on behalfof Board For Brawn Biotgch Limited Place: Delhi CIN NO.: L74899DL1985PLC022468 <. for betton Uife ‘ Works : Plot No. 85, Basement & Ground Floor, Pace City-1, Sector-37, Gurugram, Haryana- 122001, INDIA J Email: distribution@brawnlabs.in | Website : www.brawngroup.in : Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331 BRAWN BIOTECH LTD, Email: solution@brawnbiotech.com iR LG BRAWN BIOTECH LIMITED 9028F CIN:L74899DL1985PLC022468 REGD. OFFICE: C-64, Lajpat Nagar-1, New Delhi 110024 BRAWN BIOTECH LTD. Rs.in Lacs Statement of Assets and Liabilities as on 30th September 2026 Particulars 30-Sep-26 31-Mar-26 Un-Audited Audited [ASSETS (1) Non-Current Assets Property, Plant, Equipment & Intangible Assets 30.49 36.47 Financial Assets s -Investment s - Trade Receivable - 191.85 -Loan - Deferred Tax Asset (Net) 145.41 145.41 ‘Total Non-Current Assets 175.91 37373 (2) Current Assets Inventories 682.63 1,006.21 Financial Assets = " |- Trade Recsivables - 706.71 354.77 - Cash and cash equivalents 18.73 28.06 -Loan 0.90 132 - Other Financial Assets 134.67 127.77 [Curtent Tax Assets (Net) - > [Other Current Assets 195.23 193.86 ‘Total Current Assets 1,738.88 1,711.99 [TOTAL ASSETS 1,914.78 2,085.72 EQUITY AND LIABILITIES EQUITY [Equity Share Capital 300.03 300.03 [Other Equity 153.17 133.91 TOTAL EQUITY 453.20 433.94 LIABILITIES (1) Non-current Liabilities Financial Liabilities - Trade Payable - 128.97 - Other Financial Liabiliies = [Provisions = 5.80 Deferred Tax liabilities (Net) Total Non-Current Liabilities ol 134.77 (2) Current Liabilities Financial Liabilities - Trade Payables 1,401.93 1,440.86 - Other Financial Liabilities - 33.21 Other current liabilities 4373 36.82 Provisions 15.93 6.12 Current tax liabilities - = ‘Total Current Liabilities 1,461.59 1517.02 [TOTAL EQUITY AND LIABILITIES 1,914.78 2,085.72 For and on behalf of Board For Brawn Biotech Limited ] Gupta IN/NO. 00974969 Plice : New Delhi Date : 05-11-2026 ——=o— mwa CIN NO.: L74899DL1985PLC022468 <. for betten life Works : Plot No. 85, Basement & Ground Floor, Pace City-1, Sector-37, Gurugram, Haryana- 122001, INDIA Email: distribution@brawnlabs.in | Website : www.brawngroup.in Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331 BRAWN BIOTECH LTD. Email: solution@brawnbiotech.com BRAWN BIOTECH LIMITED BRAWN BIOTECH LTD. CINL74899DL1985PLCO22468 REGD. OFFICE: C-64, Lajpat Nagar-1, New Delhl 110024, Cash Flow Statement forthe half year ended 30th September, 2026 Re Intacs. Particulars Forthe half year ended For the yaar ended 30.09.2025 31032026 % Cash flow from operating activites et Prafit/ (Loss] before extraordinary tems and tax 1846 [Adustments f [Showing first 8,000 characters — download PDF for full document]